Experience of IPOM Technique in Laparoscopic Ventral Hernia Repair
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorSohag University
About this trial
evaluate the clinical experience of Sohag University Hospital with laparoscopic intraperitoneal onlay mesh repair for ventral hernias, assessing operative feasibility, intraoperative complications, postoperative recovery and short-term surgical outcomes, in order to determine its safety and effectiveness in a regional setting.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Adult patients aged 18 years or older.
Patients diagnosed clinically and/or radiologically with primary ventral hernia.
Patients planned for elective laparoscopic ventral hernia repair using the IPOM technique.
Disqualifiers
Patients unfit for general anesthesia or laparoscopic surgery.
Complicated hernias requiring emergency open surgery, such as strangulated hernia, bowel ischemia, perforation, or generalized peritonitis.
Incisional ventral hernias
Recurrent hernias
Trial population
The study will include adult patients with primary ventral hernias who are eligible for elective laparoscopic ventral hernia repair using the IPOM technique Adult patients aged 18 years or older. Patients diagnosed clinically and/or radiologically with primary ventral hernia. Patients planned for elective laparoscopic ventral hernia repair using the IPOM technique.
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
30 Participants
are grouped into 1 trial groupGroup A: patients with ventral hernia
Trial outcomes
Primary outcomes
1
the safety and effectiveness of laparoscopic IPOM repair for ventral hernia,
The primary outcome will be the safety and effectiveness of laparoscopic IPOM repair for ventral hernia, assessed by postoperative complication rate during the follow-up period.
Time frame
3 monthsLocations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: